Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.
- DOI
- 10.1007/s00277-026-07221-8
- Published
- 2026 Aug 7
- Container
- Annals of hematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-026-07221-8,
title = {Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.},
author = {Lyu C and Meng H and Pu Y and Luan X and Lyu H and Xiao X and Zhao M},
year = {2026},
journal = {Annals of hematology},
doi = {10.1007/s00277-026-07221-8},
url = {https://doi.org/10.1007/s00277-026-07221-8}
}RIS
TY - JOUR TI - Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation. AU - Lyu C AU - Meng H AU - Pu Y AU - Luan X AU - Lyu H AU - Xiao X AU - Zhao M PY - 2026 JO - Annals of hematology DO - 10.1007/s00277-026-07221-8 UR - https://doi.org/10.1007/s00277-026-07221-8 ER -
APA
C, L., H, M., Y, P., X, L., H, L., X, X., & M, Z. (2026). Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.. Annals of hematology. https://doi.org/10.1007/s00277-026-07221-8
Source records
- pubmed · retrieved 2026-09-26T15:53:37.938Z